Ir al contenido principal

coagulation factor XII

The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.

Selecciones de videos para Genes
Biblioteca de videos

Normal function

The F12 gene provides instructions for making a protein called coagulation factor XII. Coagulation factors are a group of related proteins that are essential for normal blood clotting (coagulation). After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. Factor XII circulates in the bloodstream in an inactive form until it is activated, usually by coming in contact with damaged blood vessel walls. Upon activation, factor XII interacts with coagulation factor XI. This interaction sets off a chain of additional chemical reactions that form a blood clot.

Factor XII also plays a role in stimulating inflammation, a normal body response to infection, irritation, or injury. When factor XII is activated, it also interacts with a protein called plasma kallikrein. This interaction initiates a series of chemical reactions that lead to the release of a protein fragment (peptide) called bradykinin. Bradykinin promotes inflammation by allowing fluids to leak through the blood vessel walls into body tissues (vascular permeability). This leakage causes the swelling that accompanies inflammation.

Conditions referring to this gene or chromosome

Otros nombres

coagulation factor XII (Hageman factor)

FA12_HUMAN

HAE3

HAEX

HAF

Hageman factor

Related patient information and medicines

Pruebas de coagulación sanguínea

Patient information leaflet

Pruebas de coagulación sanguínea

Pruebas de coagulación sanguínea are used to diagnose and assess bleeding problems and to monitor people who take warfarina u otro anticoagulante medicines. You may be advised to have blood clotting tests: If you h... These chemicals then react with other chemicals and proteins in the plasma, called clotting factors. There are 13 known clotting factors which.

Pre-eclampsia

Patient information leaflet

Pre-eclampsia

The National Institute for Health and Care Excellence (NICE) recommends that women at increased risk of developing pre-eclampsia should take low-dose aspirin. NICE recommends 75-150 mg asp... The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare pero serious complication is disseminated intravascular.

Trombofilia

Patient information leaflet

Trombofilia

El clotting cascade makes the sangre solidify into a clot, which sticks to the injured part of the blood vessel. Small particles in the blood, called platelets, also help to form the clot. There are also natural chemicals in the blood which act against the clotting system, to stop the blood clotting too much. Thrombophilia occurs if the normal.

esófago de Barrett

Patient information leaflet

esófago de Barrett

The coil then emits heat energy which destroys the abnormal cells. Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR) This is a procedure that is done via.

Hemorroides

Patient information leaflet

Hemorroides

Banding treatment (rubber band ligation) Banding is the most commonly used piles treatment, especially for grade 2 and 3 piles. Coagulación/Foto-coagulación infrarroja This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding.

Anticoagulantes

Patient information leaflet

Anticoagulantes

In 2021, the UK's National Institute for Health and Care Excellence (NICE) recommended that DOACs should be the preferred option for AF, instead of warfarin. These activated platelets and the damaged tissue release chemicals which react with other chemicals and proteins in the blood, called clotting factors. There are 13 known clotting factors.

Lecturas adicionales y referencias

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.
  • 11 Mar 2024 | Última versión
  • 1 Mar 2024 | Publicado originalmente

Únete a la conversación

Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.

Aviso legal: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia en línea, tratamientos y servicios de salud

Acceso sencillo a tratamientos y servicios de salud confiables en línea.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.